A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. (Q40229800)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2006
edit
Language Label Description Also known as
English
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.
scientific article published on September 2006

    Statements

    A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit